Report Overview
In 2025, the Global CBD Pet Products Market was valued at US$396.4 million, projected to grow at a CAGR of 29.5% from 2026 to 2035, potentially reaching US$5130.9 million by 2035. North America dominated the market with over 45.1% share and a revenue of US$178.76 million in 2025.
Market Drivers
- Pet Humanization: Increased consumer spending on wellness treatments for pets.
- Regulatory Trends: Growing consumer acceptance amid regulatory ambiguity regarding CBD’s veterinary use.
Key Statistics
- Dogs held a 63.4% market share in 2025.
- Oils & Tinctures accounted for 34.5% of the market.
- Joint Pain Relief constituted 32.4% of product uses.
Distribution Channels
- Pet Specialty Stores claimed 43.8% of market share.
- Fastest-growing segment: E-commerce.
Regional Analysis
- North America leads at 45.1% market share.
- Asia-Pacific is the fastest-growing region.
Market Restraints
- Federal Restrictions: CBD products remain unapproved for pet use by the FDA, limiting distribution and compliance.
Opportunities
- Focus on Feline-Specific Products can enhance market growth as cat ownership rises.
Key Players
- Notable companies include Garmon Corp., Canna-Pet LLC, Charlotte’s Web, and Pet Releaf.
Recent Developments
- Garmon Corp. expanded its product range in March 2026 to enhance distribution.
- cbdMD‘s acquisition of Bluebird Botanicals in January 2026 highlighted strategic market consolidation.
Geopolitical Impact
Ongoing geopolitical tensions have disrupted supply chains and raised costs, prompting shifts toward domestically-produced products due to increased consumer preference for traceable sources.
Conclusion
The CBD Pet Products Market represents a robust growth opportunity driven by evolving pet care trends, yet challenges such as regulatory constraints and consistent product quality must be navigated for sustained expansion.
This summary encapsulates key aspects of the market, including growth projections, drivers, restraints, distribution channels, and notable industry developments.
